# Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa

> **NCT00244387** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 506 (actual)

## Conditions studied

- Parkinson Disease, Idiopathic

## Interventions

- **DRUG:** SPM 962

## Key facts

- **NCT ID:** NCT00244387
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 506 (ACTUAL)
- **Last updated:** 2014-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244387, "Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00244387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*